Spatiotemporal controlled delivery of nanoparticles to injured vasculature
There are a number of challenges associated with designing nanoparticles for medical applications. We define two challenges here: (i) conventional targeting against up-regulated cell surface antigens is limited by heterogeneity in expression, and (ii) previous studies suggest that the optimal size o...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
National Academy of Sciences
2011
|
| Online Access: | http://hdl.handle.net/1721.1/60889 https://orcid.org/0000-0002-1381-8923 https://orcid.org/0000-0003-4255-0492 |